BBVA USA’s Chemed CHE Stock Holding History

BBVA USA’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$894K	Sell	1,921 -160	-8%	-$75.4K	0.05%	279
2021 Q2	$987K	Buy	+2,081	New	+$999K	0.06%	270

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BBVA USA's CHE Position: Q3 2021 in Review

BBVA USA reduced its Chemed (CHE) stake by 7.7% in Q3 2021, selling an estimated $75.4K and leaving 1,921 shares worth $894K. The position accounts for 0.05% of the portfolio, ranked #279.

BBVA USA first reported a position in CHE in Q2 2021 and has held it in 2 quarters since. The position peaked at $987K in Q2 2021. 403 funds tracked by Wall St. Rank hold CHE as of Q3 2021.

BBVA USA held 1,921 shares of Chemed worth $894K as of Q3 2021.
BBVA USA sold 160 Chemed shares in Q3 2021, an estimated $75.4K.
Chemed made up 0.05% of BBVA USA's portfolio in Q3 2021, its #279 holding.
BBVA USA first reported a position in Chemed in Q2 2021 and has held it in 2 quarters since.
BBVA USA's Chemed position peaked at $987K in Q2 2021.
403 funds tracked by Wall St. Rank held Chemed as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.